The potent small molecule integrin antagonist THR-687 is a promising next-generation therapy for retinal vascular disorders

Published 2018 View Full Article

  1. Home
  2. Publications
  3. Publication Search
  4. Publication Details
Title
The potent small molecule integrin antagonist THR-687 is a promising next-generation therapy for retinal vascular disorders
Authors
Keywords
-
Journal
EXPERIMENTAL EYE RESEARCH
Volume 180, Issue -, Pages 43-52
Publisher
Elsevier BV
Online
2018-11-23
DOI
10.1016/j.exer.2018.11.022

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now
Webinars Posters Questions Hubs Funding Journals Articles Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.